Risperidone Kit
Product Images NDC 70121-2626

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 68 technical images submitted to the FDA as part of the official labeling for Risperidone (NDC 70121-2626). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 1)

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 10)

1 (Risperidone For Extended Release Injectable Suspen 10)
An instructional illustration showing incorrect handling of a vial, specifically a vial labeled Risperidone Kit for intramuscular use by Amneal Pharmaceuticals. The image highlights improper technique in handling or preparing the vial, indicated by an 'Incorrect' label in the upper left corner.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 11)

1 (Risperidone For Extended Release Injectable Suspen 11)
Instructional text panel advising to remove the vial adapter from the sterile blister only when ready to remove the white cap from the prefilled syringe in the Risperidone kit.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 12)

1 (Risperidone For Extended Release Injectable Suspen 12)
An instructional illustration showing a person removing a protective cap from a vial, demonstrating preparation steps for using the Risperidone intramuscular injection kit by Amneal Pharmaceuticals LLC.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 13)

1 (Risperidone For Extended Release Injectable Suspen 13)
An instructional illustration showing a hand holding a syringe or injector device, related to the Risperidone intramuscular injection kit from Amneal Pharmaceuticals LLC. The image focuses on the positioning of fingers on the device, likely demonstrating use or administration technique.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 14)

1 (Risperidone For Extended Release Injectable Suspen 14)
Instructional illustration showing a hand holding a cartridge incorrectly for administration, indicated by a symbol marking it as incorrect. This is part of usage guidance for Risperidone intramuscular injection kit by Amneal Pharmaceuticals LLC.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 15)

1 (Risperidone For Extended Release Injectable Suspen 15)
An instructional illustration showing hands snapping off the cap of a syringe with the text 'SNAP!' above. Below, a diagram depicts a syringe without a cap with the accompanying text: 'When the cap is removed, the syringe will look like this.' This is associated with a risperidone intramuscular kit by Amneal Pharmaceuticals LLC.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 16)

1 (Risperidone For Extended Release Injectable Suspen 16)
Instructional illustration showing a hand holding a vial and inserting a syringe into it with a downward arrow indicating to press down, accompanied by a circular arrow indicating a twisting motion, likely demonstrating how to prepare an intramuscular injection for Risperidone kit by Amneal Pharmaceuticals LLC.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 17)

1 (Risperidone For Extended Release Injectable Suspen 17)
Instructional text panel indicating that vial contents will be under pressure and advising to keep holding the plunger rod down with thumb. This appears to be part of administration instructions for the Risperidone intramuscular kit by Amneal Pharmaceuticals LLC.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 18)

1 (Risperidone For Extended Release Injectable Suspen 18)
An instructional diagram showing two hands preparing an intramuscular injection kit. One hand holds a vial while the other hand uses a syringe to draw liquid from the vial, indicated by a downward arrow. The image is likely part of usage instructions for the Risperidone intramuscular injection kit by Amneal Pharmaceuticals LLC.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 19)

1 (Risperidone For Extended Release Injectable Suspen 19)
Illustration showing the preparation steps for an intramuscular injection kit. It depicts a hand shaking a vial and holds a syringe above it with arrows indicating an up-and-down motion. A timer graphic shows a duration of 10 seconds, suggesting the vial should be shaken for this time period before use.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 2)

1 (Risperidone For Extended Release Injectable Suspen 2)
An instructional diagram labeled to identify parts of a medical cap or stopper including the 'Luer Opening' at the top, the 'Spike tip' in the center, and the 'Skirt' around the base.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 20)

1 (Risperidone For Extended Release Injectable Suspen 20)
An illustration demonstrating the preparation of an intramuscular injection kit for Risperidone. The image shows a gloved hand holding a vial inverted above a syringe, with an arrow indicating the direction to pull or draw the medication into the syringe.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 21)

1 (Risperidone For Extended Release Injectable Suspen 21)
An instructional diagram showing a hand holding a vial and a syringe, with an arrow indicating the vial cap being twisted off and another arrow pointing to the syringe, illustrating the process of preparing an intramuscular injection from a vial.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 22)

1 (Risperidone For Extended Release Injectable Suspen 22)
An instructional diagram showing recommended intramuscular injection sites for Risperidone kit by Amneal Pharmaceuticals. The left panel illustrates a deltoid injection with a 1-inch needle, while the right panel shows a gluteal injection site using a 2-inch needle. Both panels include an anatomical silhouette and corresponding needle depiction indicating proper administration locations.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 23)

1 (Risperidone For Extended Release Injectable Suspen 23)
An instructional illustration showing hands demonstrating how to open a blister or strip containing two sterile syringes or ampules, with an inset emphasis on peeling back the protective cover.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 24)

1 (Risperidone For Extended Release Injectable Suspen 24)
Illustration showing a hand holding a syringe with arrows indicating an up-and-down motion, suggesting proper technique for mixing or preparing an intramuscular injection in a medical kit.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 25)

1 (Risperidone For Extended Release Injectable Suspen 25)
An instructional illustration showing hands opening or snapping a protective cap from a syringe or similar device, presumably part of the Risperidone intramuscular injection kit by Amneal Pharmaceuticals LLC.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 26)

1 (Risperidone For Extended Release Injectable Suspen 26)
An instructional illustration showing the preparation of a syringe from a vial or ampule, associated with an intramuscular injection kit. It depicts a hand holding the syringe with a protective cap being removed, and an upward arrow indicating the removal direction.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 27)

1 (Risperidone For Extended Release Injectable Suspen 27)
An anatomical illustration showing the back view of a human figure. Arrows point to the 'Deltoid' region on the upper arm and the 'Gluteal' region on the buttocks, indicating common injection sites for the intramuscular Risperidone kit by Amneal Pharmaceuticals LLC.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 28)

1 (Risperidone For Extended Release Injectable Suspen 28)
An instructional illustration showing a hand opening a small vial by twisting off its top and dispensing the liquid onto a flat surface. A close-up inset labeled 'AFTER' depicts the vial with its top removed, indicating the state after opening.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 29)

1 (Risperidone For Extended Release Injectable Suspen 29)
An instructional illustration showing a hand disposing of a used syringe and needle into a sharps disposal container labeled with a biohazard symbol. The image emphasizes safe disposal of intramuscular injection equipment, consistent with the Risperidone intramuscular kit usage.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 3)

1 (Risperidone For Extended Release Injectable Suspen 3)
Illustration of a risperidone intramuscular injection kit syringe showing labeled components including the plunger rod, diluent, white collar, and white cap.*
FDA Label Image

051 (Risperidone For Extended Release Injectable Suspen 30)

051 (Risperidone For Extended Release Injectable Suspen 30)
Chemical structure diagram of risperidone, the active ingredient in the Risperidone intramuscular kit by Amneal Pharmaceuticals LLC.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 31)

1 (Risperidone For Extended Release Injectable Suspen 31)
Label reading 'SINGLE-DOSE DEVICE' in white uppercase letters on a black background. The image likely refers to a packaging component of a pharmaceutical product.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 32)

1 (Risperidone For Extended Release Injectable Suspen 32)
An instructional diagram showing parts of a vial stopper, labeled with Luer Opening at the top center, Spike Tip entering through the middle, and Skirt around the bottom edge. The illustration appears to explain vial stopper components and configuration.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 33)

1 (Risperidone For Extended Release Injectable Suspen 33)
Illustration of a risperidone intramuscular injection kit component showing the diluent container with a white collar and white cap on one end and a plunger rod on the other. The diagram labels the parts to identify the diluent, plunger rod, white collar, and white cap.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 34)

1 (Risperidone For Extended Release Injectable Suspen 34)
Illustration of a vial for Risperidone intramuscular kit showing a colored cap and labeled contents as microspheres inside the vial.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 35)

1 (Risperidone For Extended Release Injectable Suspen 35)
Illustration showing two intramuscular injection kits for Risperidone with labeled components. One labeled 'Deltoid 1-Inch' features a shorter needle and safety device, while the other labeled 'Gluteal 2-Inch' has a longer needle with a transparent needle protector and needle safety device.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 36)

1 (Risperidone For Extended Release Injectable Suspen 36)
An illustration showing a rectangular box representing a medication kit and a clock icon indicating a 30-minute duration. This likely visually communicates a preparation or administration time related to the product.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 37)

1 (Risperidone For Extended Release Injectable Suspen 37)
An instructional illustration showing a hand removing the cap from a vial, presumably part of the Risperidone intramuscular injection kit by Amneal Pharmaceuticals LLC. The image demonstrates preparing the vial for use by lifting the protective cap.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 38)

1 (Risperidone For Extended Release Injectable Suspen 38)
Illustration showing a hand holding a single-dose vial or ampule of Risperidone intramuscular injection from an angled view, likely intended to depict preparation or administration steps for the medication kit by Amneal Pharmaceuticals LLC.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 39)

1 (Risperidone For Extended Release Injectable Suspen 39)
An instructional illustration showing a hand holding a vial with a stopper and another hand pressing down on the stopper, indicating the action to push down. This likely demonstrates how to prepare or access the medication from the vial in an intramuscular injection kit.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 4)

1 (Risperidone For Extended Release Injectable Suspen 4)
Illustration of a vial representing a Risperidone kit for intramuscular use. The vial features a colored cap and contains microspheres visible inside the container. The diagram labels these two main components, the colored cap and the microspheres.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 40)

1 (Risperidone For Extended Release Injectable Suspen 40)
Illustration showing an incorrect method of handling a vial, with a hand pressing or squeezing the vial in an improper way. The image includes an 'Incorrect' label indicating the action is not recommended. The vial is part of a kit dosage form for intramuscular administration.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 41)

1 (Risperidone For Extended Release Injectable Suspen 41)
Text panel instructing to remove the vial adapter from the sterile blister only when ready to remove the white cap from the prefilled syringe. This instruction is part of a Risperidone intramuscular injection kit by Amneal Pharmaceuticals LLC.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 42)

1 (Risperidone For Extended Release Injectable Suspen 42)
An instructional illustration showing the removal of a protective cap from a vial, presumably part of the Risperidone intramuscular injection kit by Amneal Pharmaceuticals LLC. A hand is lifting the cap off the vial, indicated by an upward arrow.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 43)

1 (Risperidone For Extended Release Injectable Suspen 43)
An instructional illustration showing a hand holding and positioning a small rectangular component, likely part of the Risperidone intramuscular injection kit from Amneal Pharmaceuticals. The image focuses on demonstrating correct grip or placement of the component within the kit.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 44)

1 (Risperidone For Extended Release Injectable Suspen 44)
An instructional illustration showing a hand holding an injectable medication device incorrectly, indicated by the label "Incorrect." This diagram is part of usage instructions for the Risperidone intramuscular kit provided by Amneal Pharmaceuticals LLC.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 45)

1 (Risperidone For Extended Release Injectable Suspen 45)
An instructional illustration showing two hands snapping off the cap of a syringe. Below is an image of the syringe without the cap, with accompanying text explaining that the syringe will appear as shown when the cap is removed. The syringe is part of a medication kit for intramuscular administration.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 46)

1 (Risperidone For Extended Release Injectable Suspen 46)
An instructional illustration showing hands using a syringe to draw medication from a vial. One hand holds the vial steady while the other depresses the syringe plunger down. An arrow points downward indicating the action, and a curved arrow emphasizes a twisting motion on the vial's cap or syringe component.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 47)

1 (Risperidone For Extended Release Injectable Suspen 47)
A drug information panel providing a usage warning related to vial contents and plunger rod operation, emphasizing the risk of pressure and advising to keep holding the plunger rod down with the thumb.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 48)

1 (Risperidone For Extended Release Injectable Suspen 48)
An instructional illustration showing a two-handed technique to prepare an intramuscular injection from a vial. One hand holds the vial while the other hand pushes a syringe plunger downward, indicating aspiration or medication withdrawal. The image corresponds to preparation steps for an injectable kit medication.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 49)

1 (Risperidone For Extended Release Injectable Suspen 49)
An instructional illustration showing a hand holding a vial and syringe assembly, with arrows indicating an up-and-down shaking motion and a timer icon displaying '10 secs.' This diagram demonstrates how to shake the vial-syringe before use as part of the Risperidone IM injection kit by Amneal Pharmaceuticals LLC.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 5)

1 (Risperidone For Extended Release Injectable Suspen 5)
An instructional diagram showing two types of intramuscular injection devices for Risperidone. One device is labeled for the deltoid muscle with a 1-inch needle, and the other for the gluteal muscle with a 2-inch needle. Both feature a transparent needle protector and a needle safety device.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 50)

1 (Risperidone For Extended Release Injectable Suspen 50)
An instructional illustration showing the preparation of an intramuscular injection using a vial and syringe. The image depicts a hand holding a vial upside down and a syringe needle inserted into the vial, with an arrow indicating downward motion, likely demonstrating how to draw medication into the syringe.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 51)

1 (Risperidone For Extended Release Injectable Suspen 51)
An instructional illustration showing hands preparing an intramuscular injection using a vial and syringe. One hand holds the vial upside down and the other hand draws medication into the syringe. Arrows indicate the steps of inverting the vial and pulling the syringe plunger.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 52)

1 (Risperidone For Extended Release Injectable Suspen 52)
An instructional diagram showing two intramuscular injection sites for Risperidone Kit by Amneal Pharmaceuticals. The left side illustrates the deltoid injection site with a 1-inch needle, indicated by a green label. The right side shows the gluteal injection site with a 2-inch needle, indicated by a yellow label. Visuals include human body outlines and needle length references.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 53)

1 (Risperidone For Extended Release Injectable Suspen 53)
An instructional black and white illustration showing hands peeling back a foil or paper cover from a component within a kit, likely related to the Risperidone intramuscular injection kit by Amneal Pharmaceuticals LLC.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 54)

1 (Risperidone For Extended Release Injectable Suspen 54)
An instructional illustration showing a hand operating a device, pushing and pulling a plunger or handle indicated by up and down arrows, likely demonstrating use of an intramuscular injection kit component.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 55)

1 (Risperidone For Extended Release Injectable Suspen 55)
An instructional diagram showing a hand manipulating a device with a cap or protective cover being removed by lifting it upward. The image likely illustrates a step in preparing an intramuscular injection, consistent with a medication administration kit.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 56)

1 (Risperidone For Extended Release Injectable Suspen 56)
An instructional illustration showing a hand holding a syringe with the cap being removed by pulling upward while another hand uses fingers to assist in removing the cap. This diagram likely relates to preparation steps for using the Risperidone intramuscular injection kit.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 57)

1 (Risperidone For Extended Release Injectable Suspen 57)
An illustration showing a human figure from the back with arrows indicating two intramuscular injection sites labeled as 'Deltoid' on the upper arm and 'Gluteal' on the buttock area.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 58)

1 (Risperidone For Extended Release Injectable Suspen 58)
An instructional diagram showing the preparation of a Risperidone intramuscular injection kit. The image depicts a hand breaking open a vial top, with a magnified circular inset illustrating the vial after opening. The illustration guides users on how to prepare the medication for administration.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 59)

1 (Risperidone For Extended Release Injectable Suspen 59)
An instructional illustration showing a hand holding a syringe over a biohazard sharps disposal container with an open lid. The image depicts the safe disposal of injectable medication sharps, relevant to a Risperidone intramuscular injection kit by Amneal Pharmaceuticals LLC.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 6)

1 (Risperidone For Extended Release Injectable Suspen 6)
An instructional illustration showing a rectangular box, likely representing the product kit, with a clock icon indicating a 30-minute time interval, suggesting a wait or observation period related to the product use.*
FDA Label Image

125 (Risperidone For Extended Release Injectable Suspen 60)

125 (Risperidone For Extended Release Injectable Suspen 60)
Label for risperiDONE Extended-Release Injectable Suspension, 12.5 mg per vial, a single-dose intramuscular injection kit by Amneal Pharmaceuticals LLC. The label includes dosage instructions for deltoid or gluteal injection, barcode, and manufacturing details. It features a light blue and white background with a peel area marked for batch coding.*
FDA Label Image

1250 (Risperidone For Extended Release Injectable Suspen 61)

1250 (Risperidone For Extended Release Injectable Suspen 61)
Packaging label for RisperiDONE for Extended-Release Injectable Suspension 12.5 mg/vial, a single-dose kit for intramuscular injection by Amneal Pharmaceuticals LLC. The label includes dosing details, storage instructions to keep the package refrigerated, tamper-evident areas, barcode, and regulatory information. The kit contains a vial of extended-release risperidone microspheres and components for deltoid or gluteal injection.*
FDA Label Image

25 (Risperidone For Extended Release Injectable Suspen 62)

25 (Risperidone For Extended Release Injectable Suspen 62)
Label for Risperidone Extended-Release Injectable Suspension 25 mg per vial. The label states it is single-dose only for deltoid or gluteal intramuscular injection. The label includes the NDC number, dosage strength, manufacturer Amneal Pharmaceuticals LLC, and a barcode section for scanning. The label also indicates a peel area and varnish-free and unwarranted areas for printing batch coding details.*
FDA Label Image

250 (Risperidone For Extended Release Injectable Suspen 63)

250 (Risperidone For Extended Release Injectable Suspen 63)
Packaging label for risperiDONE for Extended-Release Injectable Suspension, 25 mg/vial, single-dose pack. This intramuscular injection kit by Amneal Pharmaceuticals LLC includes a vial of risperidone extended-release microspheres, a pre-filled syringe of diluent, needle adapters, and safety needles. The label indicates storage in a refrigerator and provides instructions for use and handling.*
FDA Label Image

375 (Risperidone For Extended Release Injectable Suspen 64)

375 (Risperidone For Extended Release Injectable Suspen 64)
Label for Risperidone Extended-Release Injectable Suspension, 37.5 mg per vial, single-dose kit for intramuscular use. The label includes dosing instructions for deltoid or gluteal injection, a barcode, and manufacturer information for Amneal Pharmaceuticals LLC. The label also notes the vial strength and usage warnings.*
FDA Label Image

3750 (Risperidone For Extended Release Injectable Suspen 65)

3750 (Risperidone For Extended Release Injectable Suspen 65)
Packaging label for risperiDONE for Extended-Release Injectable Suspension, 37.5 mg/vial, single-dose pack for deltoid or gluteal intramuscular injection. The kit contains one 37.5 mg vial of risperidone extended-release microspheres, a pre-filled syringe with 2 mL diluent, vial adapter, and safety needles. Labeler is Amneal Pharmaceuticals LLC. Storage instructions emphasize refrigeration at 2° to 8°C. Rx only, single-dose.*
FDA Label Image

500 (Risperidone For Extended Release Injectable Suspen 66)

500 (Risperidone For Extended Release Injectable Suspen 66)
Label for risperiDONE Extended-Release Injectable Suspension, 50 mg per vial, single-dose intramuscular injection. The label specifies use for deltoid or gluteal injection only and includes the NDC 70121-1353-1. The label is from Amneal Pharmaceuticals LLC and includes storage and handling instructions, barcode, and regulatory information.*
FDA Label Image

505 (Risperidone For Extended Release Injectable Suspen 67)

505 (Risperidone For Extended Release Injectable Suspen 67)
Packaging label for risperiDONE for Extended-Release Injectable Suspension 50 mg/vial single-dose pack. The kit includes a 50 mg vial of risperidone extended-release microspheres, a pre-filled syringe with diluent, vial adapter, and safety needles for deltoid and gluteal intramuscular injection. The label indicates storage in refrigerator, single-dose usage, and is labeled by Amneal Pharmaceuticals LLC. Additional instructions and tamper-evident areas are also shown on the carton.*
FDA Label Image

101 (Risperidone For Extended Release Injectable Suspen 68)

101 (Risperidone For Extended Release Injectable Suspen 68)
Label for Risperidone diluent (2 mL) for suspension of risperidone for extended-release injectable suspension. This single-dose kit is for intramuscular injection in the deltoid or gluteal area. Distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ. The label includes a barcode and placeholders for lot number and expiration date.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 7)

1 (Risperidone For Extended Release Injectable Suspen 7)
An instructional illustration showing a vial held in one hand while the other hand removes or places a cap on the vial. The vial is unlabeled and depicted in grayscale, focusing on the action of handling the vial cap.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 8)

1 (Risperidone For Extended Release Injectable Suspen 8)
Illustration showing hands holding and preparing a single-dose vial with an integrated needle shield, likely part of the Risperidone intramuscular injection kit by Amneal Pharmaceuticals LLC.*
FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 9)

1 (Risperidone For Extended Release Injectable Suspen 9)
An instructional illustration showing a hand pressing down on a vial or medicine container, indicating an action such as unlocking or opening as part of the use process for a medical kit. The image is in grayscale with arrow guidance.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.